442 related articles for article (PubMed ID: 10080829)
1. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
Vázquez-Abad D; Grodzicky T; Senécal JL
Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
[TBL] [Abstract][Full Text] [Related]
2. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).
Conrad K; Stahnke G; Liedvogel B; Mehlhorn J; Barth J; Blasum C; Altmeyer P; Sönnichsen N; Frank KH
J Rheumatol; 1995 Jul; 22(7):1286-94. PubMed ID: 7562760
[TBL] [Abstract][Full Text] [Related]
3. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus.
Nakano M; Ohuchi Y; Hasegawa H; Kuroda T; Ito S; Gejyo F
J Rheumatol; 2000 Jun; 27(6):1403-7. PubMed ID: 10852261
[TBL] [Abstract][Full Text] [Related]
5. Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon.
Kremer L; Alvaro-Gracia JM; Ossorio C; Avila J
Clin Exp Immunol; 1988 Jun; 72(3):465-9. PubMed ID: 3048807
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
[TBL] [Abstract][Full Text] [Related]
7. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
8. CENP-O, a protein localized at the centromere throughout the cell cycle, is a novel target antigen in systemic sclerosis.
Saito A; Muro Y; Sugiura K; Ikeno M; Yoda K; Tomita Y
J Rheumatol; 2009 Apr; 36(4):781-6. PubMed ID: 19286853
[TBL] [Abstract][Full Text] [Related]
9. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
[TBL] [Abstract][Full Text] [Related]
10. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
Zimmermann C; Steiner G; Skriner K; Hassfeld W; Petera P; Smolen JS
Arthritis Rheum; 1998 Nov; 41(11):1938-45. PubMed ID: 9811047
[TBL] [Abstract][Full Text] [Related]
11. Recognition of Granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss.
Schachna L; Wigley FM; Morris S; Gelber AC; Rosen A; Casciola-Rosen L
Arthritis Rheum; 2002 Jul; 46(7):1873-84. PubMed ID: 12124872
[TBL] [Abstract][Full Text] [Related]
12. Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis.
Hudson M; Mahler M; Pope J; You D; Tatibouet S; Steele R; Baron M; ; Fritzler M
J Rheumatol; 2012 Apr; 39(4):787-94. PubMed ID: 22467948
[TBL] [Abstract][Full Text] [Related]
13. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F.
Rattner JB; Rees J; Whitehead CM; Casiano CA; Tan EM; Humbel RL; Conrad K; Fritzler MJ
Clin Invest Med; 1997 Oct; 20(5):308-19. PubMed ID: 9336656
[TBL] [Abstract][Full Text] [Related]
14. The heterogeneity of anticentromere antibodies in immunoblotting analysis.
Muro Y; Sugimoto K; Okazaki T; Ohashi M
J Rheumatol; 1990 Aug; 17(8):1042-7. PubMed ID: 2213779
[TBL] [Abstract][Full Text] [Related]
15. Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.
Earnshaw W; Bordwell B; Marino C; Rothfield N
J Clin Invest; 1986 Feb; 77(2):426-30. PubMed ID: 3511098
[TBL] [Abstract][Full Text] [Related]
16. Anticentromere autoantibodies. Evaluation of an ELISA using recombinant fusion protein CENP-B as antigen.
Vázquez-Abad D; Wallace S; Senécal JL; Joyal F; Roussin A; Earnshaw WC; Rothfield N
Arthritis Rheum; 1994 Feb; 37(2):248-52. PubMed ID: 8129780
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic survey in systemic sclerosis: correlation of aneuploidy with the presence of anticentromere antibodies.
Jabs EW; Tuck-Muller CM; Anhalt GJ; Earnshaw W; Wise RA; Wigley F
Cytogenet Cell Genet; 1993; 63(3):169-75. PubMed ID: 8387418
[TBL] [Abstract][Full Text] [Related]
19. Anti-endothelial cell antibodies from patients with limited cutaneous systemic sclerosis bind to centromeric protein B (CENP-B).
Servettaz A; Tamby MC; Guilpain P; Reinbolt J; Garcia de la Penã-Lefebvre P; Allanore Y; Kahan A; Meyer O; Guillevin L; Mouthon L
Clin Immunol; 2006 Aug; 120(2):212-9. PubMed ID: 16580263
[TBL] [Abstract][Full Text] [Related]
20. The association of primary biliary cirrhosis and systemic sclerosis is not accounted for by cross reactivity between mitochondrial and centromere antigens.
Whyte J; Hough D; Maddison PJ; McHugh NJ
J Autoimmun; 1994 Jun; 7(3):413-24. PubMed ID: 7522457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]